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ABSTRACT: Electrospun fiber scaffolds have a huge potential for
the successful treatment of infected wounds based on their unique
properties. Although several studies report novel drug-loaded
electrospun fiber-based biomaterials, many of these do not provide
information on their interactions with eukaryotic and bacterial
cells. The main aim of this study was to develop antibacterial drug-
loaded porous biocompatible polycaprolactone (PCL) fiber
scaffolds mimicking the native extracellular matrix for wound
healing purposes. Mechanical property evaluation and different
biorelevant tests were conducted in order to understand the
structure−activity relationships and reveal how the surface porosity of fibers and the fiber diameter affect the scaffold interactions
with the living bacterial and eukaryotic fibroblast cells. Cell migration and proliferation assays and antibiofilm assays enabled us to
enlighten the biocompatibility and safety of fiber scaffolds and their suitability to be used as scaffolds for the treatment of infected
wounds. Here, we report that porous PCL microfiber scaffolds obtained using electrospinning at high relative humidity served as the
best surfaces for fibroblast attachment and growth compared to the nonporous microfiber or nonporous nanofiber PCL scaffolds.
Porous chloramphenicol-loaded microfiber scaffolds were more elastic compared to nonporous scaffolds and had the highest
antibiofilm activity. The results indicate that in addition to the fiber diameter and fiber scaffold porosity, the single-fiber surface
porosity and its effect on drug release, mechanical properties, cell viability, and antibiofilm activity need to be understood when
developing antibacterial biocompatible scaffolds for wound healing applications. We show that pores on single fibers within an
electrospun scaffold, in addition to nano- and microscale diameter of the fibers, change the living cell−fiber interactions affecting the
antibiofilm efficacy and biocompatibility of the scaffolds for the local treatment of wounds.
1. INTRODUCTION
Treatment of wounds is a major concern worldwide as the
wound care costs are increasing every year. During the last few
years, the development of electrospun skin scaffolds and
fibrous wound dressings and matrices has been introduced as
alternatives to traditional wound care products to address the
problem.1
Electrospinning is a straightforward method for producing
ultrafine fibers with nano- to micrometer range diameters and
with controlled surface morphology. The fibers have unique
characteristics, for instance, large specific surface areas and
long length scales.2 Furthermore, the fibers can be used as
novel drug delivery systems (DDSs) which enable the
modification and control of the drug release.3 Over the past
few years, several poorly water-soluble active pharmaceutical
ingredients have been incorporated into nanofibers in order to
obtain a modified drug release. Drug release from nanofibers is
mostly explained to be based on diffusion, hence the porosity
of the single fibers as well as the porosity and stiffness of the
entire fiber scaffold can modify this effect.4 However, it has
also been shown that in case when 100% release from fibers is
not achieved, desorption of embedded drug from nanopores in
the fibers or from the outer surface of the fibers in contact with
the release medium is the main mechanism.5 Differences in
drug release may have different effects on the antibacterial/
antibiofilm activity of the fiber scaffolds.3,6,7
Fibers produced by electrospinning are known to have
several advantages in wound healing, as widely reported in
recent publications.8,9 Among other advantages, nanofibers
have an extracellular matrix type structure, a high specific
surface area, and a porous structure which can absorb the
wound exudate and enhance the oxygen permeability.3
Functionalization of the fibers with antimicrobial drugs adds
another dimension and enables the fight against wound
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infections, which is one of the major causes for chronic wound
and wound complication development.
Electrospinning allows producing fibers with different
morphologies and structures (e.g., porosity, alignment) from
chemically different polymeric materials and active substances
(antimicrobial agents, growth factors, etc.). From the wound
healing point of view, in addition to the selection of suitable
scaffold materials, the fiber scaffolds need to have certain
stiffness and porosity to ease the cell attachment, migration,
and proliferation. It is known that cells attach to and interact
with fibers differently than with flat substrates. Cells sense and
respond to changes in structural stiffness by increasing the
spreading on regions of higher stiffness.10 Mechanical proper-
ties such as the strength and deformability of nanofiber
scaffolds influence in vitro cell migration, proliferation, and
differentiation, along with cell morphology.11 A decreased fiber
diameter has been shown to correlate with improved
mechanical properties of the scaffolds.12,13 Whereas the
combination of both micro- and nanofibers enhances cell
penetration and infiltration to the matrix as it creates greater
pore interconnectivity and larger pore size.14 It has been shown
with several DDSs that the mechanical properties of materials
may play a part in drug loading, drug−polymer interactions,
release behavior, drug partitioning, and polymer degradation.15
It is desired that materials as well as mechanical properties of
the developed fiber scaffolds are similar to those of the skin.
However, it is not known what kind of electrospun matrix
material and structure supports the wound healing the best and
provides the best protection from bacteria. Several studies have
investigated the effect of scaffold porosity on cell inter-
action,16,17 but only few studies have addressed the effect of
surface porosity of drug-loaded fibers on cell behavior and
cell−fiber interactions.18,19 Therefore, it is of interest to reveal
whether pores on single fibers within the electrospun scaffold,
in addition to nano- and microscale diameter of the fibers,
change the living cell−fiber interactions. Interactions between
the electrospun matrix with bacteria and eukaryotic cells
determine the antimicrobial efficacy and safety of the
antimicrobial scaffolds for the local treatment of the wound.
The aim of this study is to understand the structure−activity
relationships and reveal how the fiber diameter and surface
porosity of single fibers affect their interactions with the
Figure 1. SEM micrographs of porous and nonporous electrospun PCL microfiber and nanofiber scaffolds without and with CAM (magnification
10,000×) with histogram insets. Porous microfibers, obtained using the THF/DMSO solvent system at high RH without (A) and with CAM (B).
Nonporous microfibers, obtained using the THF/DMSO solvent system at low RH without (C) and with CAM (D). Nonporous nanofibers
obtained using the AA/FA solvent system at low RH without (E) and with CAM (F). Key: AAacetic acid; CAMchloramphenicol; DMSO
dimethyl sulfoxide; FAformic acid; PCLpolycaprolactone; RHrelative humidity; THFtetrahydrofuran.
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bacterial and eukaryotic fibroblast cells. The mechanical
properties of fiber scaffolds revealed the effect of fiber
morphology and structure on the behavior of scaffolds. Cell
attachment, proliferation assays, and antibiofilm assays enabled
us to enlighten the biocompatibility and safety of the fiber
scaffolds and their suitability to be used for the treatment of
infected wounds.
2. RESULTS AND DISCUSSION
2.1. Morphology. Porous (pores on single fibers) and
nonporous microfiber scaffolds were electrospun by recently
Figure 2. Mechanical properties of dry porous and nonporous electrospun PCL microfiber and nanofiber scaffolds without and with CAM.
Representative stress−strain curves of the (A) porous MF, (B) nonporous MF, and (C) nonporous NF scaffold; (D) Young’s modulus; (E) tensile
strength at break; and (F) elongation at break. Data are presented as mean ± SD (N = 3). * Statistical significance, p < 0.05. MF = microfiber; NF
= nanofiber.
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established approaches using polycaprolactone (PCL) 15 w/v
% and tetrahydrofuran/dimethyl sulfoxide (THF/DMSO)
(90:10 % v/v) under high relative humidity (RH) (65%)
and low RH (19%) conditions (Figure 1).20 The fiber
diameters of porous fiber scaffolds ranged from 1.22 ± 0.21
(pristine) to 1.97 ± 0.30 μm (chloramphenicol [CAM]-
loaded). The surface pore diameter was found to be 0.28 ±
0.08 for pristine porous microfibers and 0.22 ± 0.08 μm for
CAM-loaded porous microfibers (Figure S1).
Nonporous nanofibers, obtained using the acetic acid (AA)/
formic acid (FA) solvent system, had a smooth surface without
any surface pores, and the fiber diameters ranged from 250 ±
110 (pristine) to 450 ± 110 nm (CAM-loaded). The fiber
diameters of nonporous microfibers were 1.0 ± 0.48 (pristine)
to 1.5 ± 0.65 μm (CAM-loaded). As expected, the largest
pores between the fibers were detected for microfiber scaffolds
(13.24−21.87 μm) and the smallest pores for nanofiber
scaffolds (2.88−3.65 μm). Full morphology and solid-state
characterization of these fiber scaffolds have been reported
previously.20
2.2. Mechanical Properties. The fiber scaffolds consisting
of porous and nonporous microfibers and nonporous nano-
fibers (pristine and CAM-loaded fiber scaffolds) showed
different mechanical properties (Figure 2).
Nonporous microfiber scaffolds stretched the most before
breaking (Figure 2B). Nanofiber scaffolds were more stiff and
plastic compared to porous microfiber scaffolds (Figure 2A,C).
The tensile strength and Young’s modulus were the highest
with nonporous microfiber scaffolds which were also found to
be statistically relevant. Nonporous microfiber scaffolds had
significantly higher tensile strength compared to the porous
microfiber ones and increased Young’s modulus values,
indicating that the scaffolds behave differently in plastic
deformation (Figure 2D,E). The elongation at break was found
to be higher with porous microfiber scaffolds compared to that
with nonporous nanofiber and microfiber scaffolds (Figure
2F). There was a trend showing a higher Young’s modulus and
tensile strength with nonporous nanofibers compared to
porous microfibers. This correlates with the literature reporting
that fibers with a smaller diameter have a higher tensile
strength.21,22 In general, drug-loaded fibers showed slightly
increased tensile strength and Young’s modulus except for
nonporous microfibers but decreased elongation at break
compared to those of pristine PCL scaffolds (Figure 2D−F).
However, the latter was not statistically relevant for each
composition. There exists a correlation between the macro-
structural and microstructural porosities of fibers, which can be
tracked by the free volume changes through the ortho-
positronium (o-P) atom lifetime values.23,24 The size of the
free volume of pores (e.g., holes) determines the mechanical
properties of the fibers and also the drug release from the
Figure 3.Mechanical properties (Young’s modulus, tensile strength, and elongation at break) of dry and wet (3 min wet and 24 h wet) electrospun
fiber scaffolds without and with CAM. (A) Porous microfibers without and with CAM; (B) nonporous microfibers without and with CAM; (C)
nonporous nanofibers without and with CAM; and (D) elongation at break of all electrospun fibrous scaffolds. MF = microfiber; NF = nanofiber.
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samples.25,26 The decreased free volume is known to increase
the tensile strength of fibers.27
The mechanical properties of fiber scaffolds are very
important for wound healing and tissue regeneration
applications. In our study, the tensile strength was the highest
for nonporous microfiber scaffolds compared to those of
porous microfiber and nonporous nanofiber scaffolds (Figure
2E). In addition, the surface porosity on single fibers
significantly increased the elasticity of the microfiber scaffolds
shown in higher elongation at break values (Figure 2F).
Previously, it has been stated that the tensile strength of PCL
fibers increase significantly when the diameter of the fibers is
reduced below 500 nm, however not in our case.28 PCL fibers
with larger diameters are known to increase the elongation at
break, which was also confirmed in the present study (Figure
2F).21 The scaffolds have to be strong enough to keep their
structure when applied on the wounds and easily removable
without damaging the newly formed tissue. For tissue scaffolds,
the stiffness dictates the cell−fiber scaffold interactions.29 Focal
adhesions allow cells to push or pull themselves along the
matrix, so the matrix should have sufficient stiffness to resist
deformations by cell tractions; however, it is more complex
with electrospun scaffolds where the cells can pull themselves
in any direction.30 While mimicking the skin, their mechanical
properties can differ depending on their origin, but the tensile
strength for the native skin is approximately 20 MPa31 and
Young’s modulus range from 0.008 MPa32 up to 70 MPa.31
Elongation at break values for the skin range between 35 and
115%.33
It is believed that in addition to the fiber and fiber scaffold
structure, the effect of solvents on the PCL structure (e.g.,
polymer crystallinity) needs to be taken into account, and this
may change the mechanical behavior of the material.34 We
confirmed that the electrospinning solution composition and
the diameter of the fibers together with the scaffold structure
all affect the mechanical properties of PCL fiber scaffolds.
Previously, several publications have characterized PCL
electrospun fibers and fiber scaffold mechanical properties,
and the values indeed vary significantly depending on the
solvent system, fiber diameter, and scaffold structure and
thickness.35 Arinstein and Zussman have suggested that the
relaxation process generated by evaporation of solvent within
electrospun fibers can significantly affect the mechanical
properties of polymeric nanofibers.36 Electrospinning of PCL
from AA is known to form brittle nanofibers that are less
elastic.37 Hence, the less elastic behavior of nanofiber scaffolds
in addition to the fiber diameter may be related to the solvents
(AA/FA) used for electrospinning.
Drug encapsulation can either increase or decrease the
mechanical properties of electrospun PCL fibers.22,38 It has
been shown that incorporation of the antibacterial drug
linezolid into PCL scaffolds improved their mechanical
properties.39 It is known that drug−polymer interactions affect
the mechanical properties of electrospun polyester fibers,15 and
as the solid-state analyses in our previous study have revealed,
different solvents may have affected the CAM−PCL
interactions at the molecular level differently.20 This may
lead to different mechanical behavior of scaffolds. Addition of
CAM to the scaffolds only slightly increased the tensile
strength of porous microfiber and nonporous nanofiber
scaffolds. However, the tensile strength and Young’s modulus
of nonporous microfiber scaffolds and the elasticity of all the
samples were decreased (Figure 2).
In order to understand the mechanical properties of PCL
scaffolds under wet conditions (e.g., mimicking wounds), the
samples were introduced into the buffer solution for 3 min and
24 h (Figure 3).
After 3 min and 24 h in buffer, there were no significant
changes observed in the mechanical properties of wet pristine
PCL scaffolds compared to their respective dry scaffolds
(Figure 3A−C). The elongation at break remained mostly
unchanged for all samples (Figure 3D). Interestingly, no
significant differences in mechanical properties (tensile
strength and Young’s modulus) were observed with CAM-
loaded scaffolds after wetting (Figure 3C). The tensile strength
of nonporous CAM-loaded nanofibers decreased under wet
conditions from 39.86 (dry) to 23.78 MPa (24 h wet) most
likely as a result of drug release; however, it was not found to
be statistically relevant. Similarly, porous microfibers with
CAM show similar trends in decreased tensile strength and
Young’s modulus values (Figure 3A).
2.3. Wettability, Swelling, and Early In Vitro Degra-
dation Behavior. It is stated that higher buffer penetration
increases the degradation of the matrix as well as the amount of
drug released.6,40 The nonporous pristine nano- and microfiber
scaffolds showed a higher swelling index compared to those of
porous microfiber scaffolds (Figure 4A). The highest swelling
index was observed for nonporous microfibers, but this was not
statistically significant. There were no relevant differences in
the weight loss of scaffolds as the weight loss for all scaffolds
was very low (Figure 4B). All CAM-loaded samples showed a
higher swelling index and weight loss compared to those of
pristine scaffolds (Figure 4A,B).
With electrospun fiber scaffolds, it has been previously
shown that the smaller diameter (nanoscale) fibers increase the
surface roughness and the fraction of the contact area of the
droplet with the air trapped between fibers.41 All pristine PCL
scaffolds showed no statistical difference in contact angle
values at the start of the experiment and after 30 s (Figure 4C);
however, all CAM-loaded samples showed decreased contact
angle values after 30 s in contact with the buffer. As expected,
CAM-containing scaffolds showed more hydrophilic surfaces,
as the drug started to dissolve and made it easier for the buffer
to penetrate into the scaffold structure. Surface porosity of
microfiber scaffolds most probably affected the surface
roughness of the fiber samples, but the effect was not observed
as a significant difference in contact angle values. It is known
that the surface roughness increases together with the apparent
contact angle of hydrophobic materials, while for hydrophilic
materials the contact angle decreases.42 Therefore, the wetting
properties of more hydrophilic surfaces should be improved by
increasing the surface roughness.
Fiber morphology and diameter may enormously affect the
behavior of electrospun fiber scaffolds under biorelevant
conditions, and consequently, their interactions with living
cells, specifically if these scaffolds are functionalized with
antimicrobial agents. PCL fibers are hydrophobic; however, the
addition of CAM made the scaffolds more hydrophilic and
induced the drug release, which has been shown previ-
ously.3,43,44 Significant swelling occurred, and in addition to
the increased swelling index, we also observed increased fiber
diameters and changed morphology (Figures 4A and S2).
Increased fiber diameters were more evident for nonporous
fiber scaffolds which supports the swelling index results
(Figures 4A and S2). However, only small degradation of
scaffolds was seen within a short contact (24 h) with the
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biorelevant medium (Figures 4A,B and S2). In addition to
wetting, drug release also takes place upon contact with the
buffer. Our previous studies have revealed that the drug release
from electrospun fiber scaffolds depends largely on the
chemistry of the materials and structural properties of the
mats. The CAM release from the present electrospun PCL
fiber scaffolds showed differences. Fastest drug release was
detected from nonporous nanofiber scaffolds, followed by
porous microfiber and nonporous microfiber scaffolds. After 96
h, the nonporous nanofibers had released about 72.6% and
porous microfibers 59.2% of CAM. In the case of nonporous
microfibers, CAM was entrapped inside the fiber scaffold, and
only about 20% of it was released within 96 h of testing.20 The
mechanical properties of PCL fiber scaffolds only slightly
changed upon being in contact with the buffer (Figure 3).
However, the contact angles of CAM-loaded scaffolds were
significantly smaller compared to pristine scaffold values after
30 s in buffer, revealing better hydrophilicity of the samples
(Figure 4).
2.4. Biological Relevance of Differently Designed
Fiber Scaffolds. 2.4.1. Fibroblast Cell Attachment and
Biocompatibility. The fibroblast attachment and biocompat-
ibility were evaluated using the MTS assay. The assay shows
the metabolically active cells that react with the tetrazolium salt
in MTS, which results in the production of soluble formazan
dye. The highest absorbance was seen with porous microfiber
scaffolds with CAM, which suggests that the cells had good
attachment and proliferation properties and indicates that the
nanoporous topology of the fiber scaffolds affects the behavior
of fibroblast cells (Figure 5).
There was no statistically significant difference in MTS
activity observed between porous and nonporous microfiber
scaffolds with CAM. However, a clear trend was seen that the
cells preferred to attach and proliferate on the porous
microfiber scaffolds as these scaffolds showed higher MTS
activity compared to that of nonporous microfibers, which was
statistically significant (p < 0.05). The presence of CAM did
not affect the behavior of cells on scaffolds during the testing
time period (Figure 5A).
In order to understand the cell−scaffold interactions better,
we tried to evaluate the fibroblast behavior and distribution on
the scaffolds by confocal fluorescence microscopy (CFM). The
3D view-constructed micrographs from CFM can be seen in
Figures 5C−E and S3. The red membrane dye used (FM4-64)
shows the cellular placement and distribution throughout the
scaffold. The highest number of cells together with the best
infiltration properties was seen with the CAM-loaded porous
scaffolds, where the cells were evenly distributed on the top
level and infiltrated through the scaffold to the lowest depth
(Figure 5C). This also correlates with the results of the MTS
assay (Figure 5A). Figure 5D shows the cell infiltration for the
nonporous microfiber scaffold. The cells were evenly
distributed on the top layer of the sample and infiltrated
similarly; however, the signal of the dye was lower than that
observed for the porous scaffold one. The latter indicates the
presence of a smaller number of cells on nonporous microfiber
scaffolds compared to that of the porous microfiber scaffolds
(Figure 5C). Furthermore, this correlates with the trends
observed in the MTS assay (Figure 5A). With nonporous
nanofiber scaffolds, the cells were evenly distributed only on
the upper layer of the sample (Figure 5E).
Cell attachment and safety studies carried out with BHK-21
cells revealed that the structure of the PCL fiber scaffolds and
single-fiber morphology (surface structure of a single fiber)
have a huge effect on the cell behavior (Figure 5). It was seen
that cells preferred to attach and penetrate more into the
Figure 4. Swelling, weight loss, and wettability of electrospun fiber
scaffolds when in contact with a buffer for different time periods. (A)
Swelling index of all fiber scaffolds; (B) weight loss of all fiber
scaffolds; and (C) contact angles of all fiber scaffolds at the start of the
experiment and after 30 s. Data are presented as mean ± SD (N = 3).
* Statistical significance, p < 0.05. MF = microfiber; NF = nanofiber.
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microfibrous elastic scaffolds compared to that on nanofibrous
less elastic scaffolds. Besides, the surface porosity of fibers and
increased hydrophilicity (verified by lowered contact angle
values and improved wettability), due to the drug release
together with improved intrusion of aqueous medium into the
scaffold structure, improved the attachment of cells on the
scaffolds. The best cellular distribution and infiltration,
compared to those of all the samples, were seen with porous
microfiber scaffolds with CAM (Figure 5C), which also
correlates with the results of the MTS assay (Figure 5A).
The nonporous nanofiber scaffolds (Figure 5E) showed
different cellular behavior as cells were distributed evenly
only on the upper layer, and no cells were seen at lower depths.
This phenomenon could be related to the fact that the pore
size affects the cellular infiltration properties.45
It has been previously shown that cells are able to
impregnate into the scaffold when its structure provokes it.46
The pore size affects the cellular dimensions and the spreading
capabilities.45 One study about cellular growth dependency on
the pore size of the matrix has suggested that fibroblasts tend
to spread along the walls of the matrix in scaffolds with pore
size above 20 μm, resulting in better infiltration properties,
while pores with smaller sizes enhance the intercell
communication and boost the extracellular matrix production.
In the case of pores smaller than these cells, it has been stated
that the cells migrate by the amoeboid movement deforming
their cytoskeleton; however, the deformation is limited to
about 10% of the nucleus size above which the degradation of
the matrix comes into play.47 Nanofibrous scaffolds have
smaller pores than microfibrous scaffolds, so this limits the
cellular penetration through the scaffolds which in turn leads to
lower attachment and proliferation properties. We observed
that the cells were more likely to attach and grow onto porous
PCL microfiber scaffolds than on nonporous PCL microfiber
scaffolds, which was also found to be statistically relevant (p <
0.05). This states that the surface porosity of single fibers
enhances the cellular attachment and proliferation properties
in the scaffolds.
No significant differences were observed in the cell
attachment between the drug-loaded and nonloaded porous
microfiber scaffolds, revealing the biocompatibility and safety
of CAM to be used in wound scaffolds within tested
concentrations. It has been highlighted previously that PCL
fibers and CAM at the concentration used are cytocompat-
ible.48,49
Several studies have discussed that the porosity and mean
pore size of electrospun fiber scaffolds affect the cell
attachment and growth,50 but to the authors’ knowledge,
only few studies have investigated the influence of single-fiber
surface pores on cell behavior which was proven in this study.
The effect of surface structure on the cell viability has been
investigated before with PCL matrices supporting our
findings.34
2.4.2. Bacterial Attachment and Biofilm Formation. No
relevant differences were observed with planktonic bacteria
comparing scaffolds with and without the drug (Figure 6A),
however, not with the biofilm bacteria (Figure 6B). The results
of Escherichia coli biofilm formation on different fiber scaffolds
revealed that the electrospun fiber scaffolds without any CAM
provide good surfaces for biofilm formation, and there are
statistically significant differences in CFU values between the
different fiber scaffolds after 48 h (Figure 6B).
Less biofilm was formed on porous and nonporous
microfiber scaffolds than that on nonporous nanofiber scaffolds
at 24 h time point, after which at 72 h time point, an increase
in CFUs was seen on nonporous nanofiber scaffolds. With
porous and nonporous microfiber scaffolds, the biofilm
formation remained basically unchanged; only small differ-
ences were observed when nonporous microfiber and porous
Figure 5. (A) MTS activity when fibroblast cells (BHK-21) were seeded onto porous and nonporous electrospun microfiber and nanofiber
scaffolds without and with CAM (N = 3), * Statistical significance, p < 0.05. MF = microfiber; NF = nanofiber. Regarding exact formulations,
reference is made to Figure 1. Cells were incubated for 48 h. (B) Confocal fluorescence microscopy (CFM) 2D micrograph of the porous
microfiber scaffold in visible light with the inset picture (white arrow) of the same showing a fluorescent signal that comes from the FM 4-64 dyed
fibroblast cells. CFM cross-section micrographs of fibroblast cells attached onto the electrospun (C) porous microfiber scaffold consisting of CAM;
(D) pristine nonporous microfiber scaffold; and (E) pristine nonporous nanofiber scaffold. The white arrows in figures (C−E) indicate the
fibroblast infiltration from 0 to 40 μm (blue line) in depth. Additional confocal images of the samples can be found in the Supporting Information
(Figure S3) together with SEM images of BHK-21 cells on fibers (Figure S4).
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microfiber scaffolds were compared, favoring the biofilm
formation on porous microfiber scaffolds (Figure 6B).
The antibiofilm activity of CAM could be seen in all drug-
loaded samples at all time points. The porous microfiber
scaffolds with CAM showed the best antibiofilm activity
compared to nonporous CAM-loaded nano- and microfiber
scaffolds, which can be clearly seen at 48 h time point. After 24
h of incubation, the porous microfiber and nonporous
microfiber scaffolds with CAM showed similar antibiofilm
activity, whereas nonporous nanofiber scaffolds with CAM
were not as efficient. After 72 h, all the drug-loaded samples
had inhibited the bacterial growth.
Fiber diameter is known to affect the ability of bacteria to
proliferate within the fibrous networks, depending on the cell
size and shape; the highest proliferation occurs when the fiber
diameter is close to that of the bacterial size.51 However, it was
recently reported that the biofilm formation on nanofibrous
PCL scaffolds (electrospun from the chloroform/ethanol
mixture) takes place and largely depends on the way bacteria
attach onto the fiber.52 The bacterial attachment is dependent
on the fiber size (preferably, at a fiber diameter of 100 nm) and
fiber coating. Organic substances of bacterial origin are a
conditioning film (e.g., coating) for interactions between
bacteria and nanofibers. The latter was found to play a
remarkable role in facilitating the subsequent adhesion of
bacterial cells to the PCL nanofibers (much smaller size
compared to that of bacteria).52 Similarly, in a recent study, a
bacterial biofilm was formed on a scaffold comprising flat
nanofibers (with an average fiber diameter of 390 nm).53 In
order to understand the bacterial attachment on the fiber
surface and the relevance of different fiber structures for
bacterial biofilm formation and potential antibiofilm activities
of the drug-loaded fiber scaffolds, biofilm formation assays
were conducted (Figure 6A,B). We also observed that biofilm
formation was favored on nanofiber scaffolds compared to that
on microfiber scaffolds. The surface topography largely affects
the biofilm formation via different mechanisms, and surfaces
with topographic features of dimensions in the submicrometric
or nanometric range have been reported to inhibit attachment
by reducing the contact area between bacterial cells and the
surface.54,55 Furthermore, nanoscale surface pores can create
energetic situations unfavorable for bacterial attachment and
induce repulsive surface−bacteria interaction forces that impair
attachment and subsequent biofilm formation.56,57 In our
study, the surface properties (surface porosity) only slightly
affected the biofilm formation, and in contrast to what was
expected, more biofilm was detected on fibers with surface
pores (Figure 6B).
With the drug-loaded fiber scaffolds, we have shown that the
drug release rate and the amount of drug left within the
sample20 also affect the E. coli biofilm formation, and
controversial results can be obtained if nanofibers release the
drug faster compared to that of microfibers (Figure 6B). Fiber
wettability, surface charge, and chemistry affect the ability of
bacterial cells to attach and proliferate throughout the
nanofiber scaffolds.58 We have previously shown that non-
porous nanofiber scaffolds exhibit faster drug release.20
Therefore, less drug remained in those fibers, and E. coli
biofilm formation was not as effectively hindered. Microfiber
scaffolds had a lower drug release rate, and more drug was still
within the fibers compared to nanofiber scaffolds providing
better antibiofilm properties. Besides, antibacterial properties
of CAM-loaded PCL fibers on planktonic bacteria were
observed, which nicely correlated with the drug release profiles
of the PCL fibers previously published for studied scaffolds.20
Unfortunately, all tested electrospun fiber scaffolds acted as
good surfaces for Pseudomonas aeruginosa biofilm formation,
and no antibacterial or antibiofilm effect was detected with
CAM-loaded PCL fiber scaffolds (Figure S5). These results
were not surprising as P. aeruginosa is known to exhibit
resistant behavior against CAM.59,60
3. CONCLUSIONS
Antibacterial CAM-loaded porous biocompatible PCL fiber
scaffolds for infected wound-healing purposes were developed.
PCL fiber scaffolds electrospun using different solvent systems
show relevant differences in their morphology, structure, and
elastic behavior, affecting their interactions with living cells
(bacterial and eukaryotic cells). It is known that electro-
spinning allows the fabrication of differently designed
structures; however, for the first time, the effect of surface
pores on drug-loaded fibers on eukaryotic and bacterial cell
attachment was revealed. Porous electrospun CAM-loaded
microfiber scaffolds (THF/DMSO) allow better fibroblast
attachment and growth compared to the nonporous electro-
spun microfiber (THF/DMSO) and nanofiber scaffolds (AA/
FA). Furthermore, the porous CAM-loaded microfiber
scaffolds offer the best antibiofilm activity against E. coli.
This study demonstrates the importance of designing the
single fiber surface porosity in addition to the fiber diameter
which may affect the drug release, mechanical properties,
Figure 6. (A) Antibacterial activity of porous and non-porous
electrospun PCL microfiber and nanofiber scaffolds without and with
CAM on E. coli and (B) biofilm formation and antibiofilm activity.
Regarding exact formulations, reference is made to Figure 1. Key:
biofilm bacteria−biofilm bacteria washed off from the fiber scaffold;
CAMchloramphenicol; MF = microfiber; NF = nanofiber;
planktonic bacteria−bacteria from the well where the fiber scaffold
was removed. Detection limit refers to the CFU that can be counted
by the plate method (200 CFU/mL).
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fiber−cell interactions, and antibiofilm activity of electrospun
fiber scaffolds for wound infection treatment.
4. EXPERIMENTAL SECTION
4.1. Materials. 4.1.1. Polymer, Solvents, and Supplies.
PCL (Mn: 80,000) (15% w/v) was used as a carrier polymer
for fiber formation. CAM (PubChem CID: 5959) was used as
an antibacterial model drug. PCL, CAM, penicillin, strepto-
mycin, and solventsTHF, DMSO, AA, FA, and form-
aldehydewere obtained from Sigma-Aldrich, Inc. (Darm-
stadt, Germany). Growth media and buffers used in this study:
Glasgow’ minimal essential medium (GMEM) (PAN Biotech,
GMBH Aidenbach, Germany), fetal bovine serum (FBS),
tryptose phosphate broth (TPB, Difco, USA), 4-(2-hydrox-
yethyl)-1-piperazineethanesulfonic acid) (HEPES), Dulbecco’s
modified Eagle’s medium (DMEM, phenol red, and serum-free
medium) (Sigma-Aldrich Inc., Darmstadt, Germany), Lennox
lysogeny broth (LB) (Sigma-Aldrich, Inc., Darmstadt,
Germany), and all other materials were of reagent grade and
were used as received without any further purification.
4.2. Electrospinning of Fiber Scaffolds. Solutions were
allowed to mix overnight with the aid of a magnetic stirrer.
Drug (CAM) was added to the electrospinning solution after
polymer (PCL) dissolution in solvent mixtures and was further
stirred for 1 h before electrospinning. The amount of CAM
was 4% w/w based on the dry weight of the solid material.
Electrospinning of fiber scaffolds with and without CAM was
performed, as previously described.20 RH within an electro-
spinning chamber was varied depending on the fiber scaffold
that was produced (porous vs nonporous) using a humidifier
AEG LBF 7138 (EHT Haustechnik GmbH, Nürnberg,
Germany). For the electrospinning of nonporous nanofibers
and microfibers, the RH of 19% (low RH) was used, and for
that of porous microfibers, 65% RH (high RH) was used. The
applied voltage was varied between 11 and 15 kV. Electrospun
fiber scaffolds were stored in airtight plastic zip-lock bags under
ambient conditions (temperature of 22 ± 1 °C and RH of 20
± 2%) until further analyses. Prior analyses, the samples were
stored at 24 h under 0% RH in a desiccator.
4.3. Morphology and Structure of Electrospun Fibers.
4.3.1. Scanning Electron Microscopy. The morphology,
diameter, and surface topography of pristine PCL and CAM-
loaded fibers were investigated using a scanning electron
microscope (Zeiss EVO 15 MA, Germany). Randomly selected
areas of fiber scaffolds were mounted on aluminum stubs and
magnetron-sputter-coated with a 3 nm platinum layer in an
argon atmosphere prior to microscopy. The mean fiber
diameter was calculated (N = 100) and presented together
with standard deviation (SD). The porosity and mean pore
diameter of the fiber scaffolds have been reported previously.20
In addition, the fiber scaffolds covered with eukaryotic cells
were also visualized under a scanning electron microscope. For
SEM analysis, the scaffolds were rinsed twice with 1×
phosphate-buffered saline (1× PBS), pH 7.4, and then fixed
with 4% formaldehyde for 30 min at RT. Then, they were
rinsed twice with 1× PBS and dehydrated with increasing
concentrations of ethanol (30, 60, and 96%). When dry, the
SEM samples were prepared as described above.
4.3.2. Confocal Fluorescence Microscopy. CFM with a
LSM710 (Carl Zeiss, Munich, Germany) and Zen software
(Zeiss) were used for the visualization of fibroblast cells after
the cell attachment and growth studies. After 48 h of cell
attachment experiment, scaffolds were removed from the
inserts and washed in 1× PBS solution, after which they were
placed in 5 μg/mL FM 4-64 (Invitrogen, Thermo Fischer,
USA) staining solution in DMSO. After 2 min, the scaffolds
were removed and placed on a microscope slide and visualized
under the microscope. To evaluate the cell penetration through
the fiber scaffolds or view them, 3D micrographs were
constructed using the z-stack images from CFM using Zen
software. The z-stack image consisted of 101 slices with a
depth of 134.95 μm, and the cell infiltration was measured
using 3D measurements.
4.4. Mechanical Analysis. Mechanical behavior of the dry
and wet fiber scaffolds was studied using a Brookfield CT3
Texture Analyzer (Middleboro, MA, USA) equipped with a 10
kg load cell. The tensile test method was used for analysis in
line with the ASTM D-638 and ISO10350:1993 mechanical
testing guidelines. TexturePro CT software (AMTEK Brook-
field, Middleboro, MA, USA) was used for data collection and
analysis. Roller Cam accessory grips (TA-RCA; width of 25
mm) were used to fix the sample. Samples were mounted
between holders at a distance of 50 mm, and the target value
for distance was 60 mm. Tensile testing was performed at a
strain rate of 1 mm/s and a trigger load of 1 g. Tests were
performed using bell-shaped electrospun fiber scaffolds (with a
length of 50 mm, a middle part of 10 mm, and widths of 20
mm from both sides and 10 mm in the middle). All
measurements were performed under ambient conditions (at
a temperature of 22 ± 1 °C and a RH of 20 ± 2%). For wet
electrospun fiber scaffolds, the scaffolds were immersed in the
biorelevant buffer solution (1× PBS) for 3 min or 24 h and
then analyzed for their mechanical properties. Each sample
group comprised at least 3−5 specimens. The mean thickness
of the fiber scaffolds varied from 0.09 up to 0.11 mm measured
using a Precision-Micrometer 533.501 (Scala Messzeuge,
Dettingen, Germany) with a resolution of 0.01 mm. Young’s
modulus (MPa, linear region) and tensile strength (zero slope)
were calculated from each corresponding stress−strain curve.
The same TexturePro CT software was used to obtain the
elongation at break (%) values.
4.5. Contact Angle, Swelling, and Early In Vitro
Degradation. In order to understand the hydrophilic/
hydrophobic nature of the fiber scaffolds and their wettability
behavior, the contact angle between the fiber scaffolds (m =
11.5 ± 0.01 mg; size 2 × 2 cm) and biorelevant 1× PBS (pH
7.4) was measured by the sessile drop method (OCA 15EC,
DataPhysics Instruments GmbH, Filderstadt, Germany). A
drop of 1× PBS buffer solution (5 μL) was applied onto the
fiber scaffolds. The contact angle measurements were taken at
time points 0 and 30 s after the liquid drop touched the surface
of the fiber scaffold. This test was carried out at RT (22 °C ±
0.3). The contact angle was analyzed using SCA20 software
(DataPhysics Instruments GmbH, Filderstadt, Germany). Each
sample was measured at least in triplicate.
For swelling index and weight loss measurements (early in
vitro degradation), a set of 4 cm2 square-shaped samples (N =
3) were cut from the fiber scaffolds, weighed, and then
immersed in 10 mL of 1× PBS solution at 37 °C for 24 h. After
that, the samples were placed on plastic Falcon Cell stainer
sieves (mesh size: 40 μm) (Fisher Scientific, Thermo Fischer,
USA) placed on a 50 mL Falcon tube to remove free surface
solution and weighed. The swelling index and weight loss were
calculated as reported previously.61
4.6. Biological Evaluation of Differently Designed
Electrospun Fiber Scaffolds. 4.6.1. Eukaryotic Cells and
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Culturing Media. Baby hamster kidney cells (BHK-21) were
used for cell studies. Fibroblasts were grown in GMEM (500
mL) supplemented with 7.5% FBS, 11 mL of 2% TPB, 10 mL
of 1 M HEPES, 100 μg/mL penicillin, and 100 μg/mL
streptomycin. Cells were maintained at 37 °C in a 5% CO2
incubator.
4.6.2. Eukaryotic Cell Attachment and Growth. Fiber
scaffolds were placed into 24-well plates using cell crown
inserts (CellCrown, Scaffdex Oy, Finland), 500 μL of BHK-21
cell suspension (consisting approximately 10,000 cells) was
seeded on the scaffolds and 700 μL of pure DMEM with
phenol red and serum was added. The number of cells was
determined using trypan blue exclusion (Invitrogen, Thermo
Fischer, USA). After 24 h of incubation, 500 μL of medium
was added. After 48 h, the scaffolds were removed from the
inserts, placed carefully in 1× PBS, and transferred to 400 μL
of DMEM (phenol red and serum-free medium). Another 100
μL of DMEM was added and 80 μL of MTS reagent (K300-
500, Biovision, USA) was also added. The cells were incubated
at 37 °C and 5% CO2. After 45 min, the scaffolds were
removed, the obtained colored media were pipetted onto a 96-
well plate, and absorbances were measured using a plate reader
(Invitrogen, Thermo Fischer, USA) at 490 nm. The graphs
show the MTS activity of cells. From the same experiment, cell
attachment and proliferation were visualized by SEM and
CFM, as explained in the section Morphology and Structure of
Electrospun Fibers. At minimum, three technical replicates
were performed.
4.6.3. Bacterial Strains and Preparation of Stocks.
Clinically relevant for wound infection facultative anaerobic
and Gram-negative bacterial strains (E. coli DSM no. 1103
(clinical isolate); P. aeruginosa DSM no.: 1117 (P. aeruginosa),
blood isolate) used in this study were obtained from the
Leibniz Institute DSMZ-German Collection of Microorgan-
isms and Cell Cultures. Preparation of DMSO stocks is
described in a study by Preem et al.3,4 and in the Supporting
Information.
4.6.4. Bacterial Attachment, Growth, and Biofilm
Formation. The biofilm formation protocol was established
based on the work of Brackman et al.62 and was already proved
suitable in our previous study.3 The schematics of the biofilm
formation experiment can be seen in Figure 7. The detailed
explanation of the biofilm formation experiment is given in the
Supporting Information.
4.7. Statistical Analyses. The results are expressed as an
arithmetic mean ± SD. Statistical analysis was performed by
applying one-way ANOVA and post hoc pairwise t-tests with
MS Excel 365 software (p < 0.05). In case of multiple
comparisons, Holm’s method was used for adjusting p-values.
The image analysis was performed and mean diameters of the
fibers (N = 100) calculated using ImageJ software 1.52e
(National Institutes of Health, Bethesda, MD, USA) were
calculated.
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(4) Zupancǐc,̌ Š.; Preem, L.; Kristl, J.; Putrins,̌ M.; Tenson, T.;
Kocbek, P.; Kogermann, K. Impact of PCL Nanofiber Mat Structural
Properties on Hydrophilic Drug Release and Antibacterial Activity on
Periodontal Pathogens. Eur. J. Pharm. Sci. 2018, 122, 347−358.
(5) Srikar, R.; Megaridis, C. M.; Yarin, A. L.; Bazilevsky, A. V.
Desorption-Limited Mechanism of Release from Polymer Nanofibers.
Proc. ASME Int. Manuf. Sci. Eng. Conf. 2008, 2, 465−474.
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